Magazine
Endocannabinoid system
The endocannabinoid system (ECS) was discovered in 1992 by a research team from the National Institute of Mental Health (NIMH, Bethesda, Maryland/USA) led by William Devane and Dr. Lumir Hanus...
Endocannabinoid system
The endocannabinoid system (ECS) was discovered in 1992 by a research team from the National Institute of Mental Health (NIMH, Bethesda, Maryland/USA) led by William Devane and Dr. Lumir Hanus...
Terpenes - Scent effect
Cannabis plants emit a very characteristic scent. Responsible for this are scent molecules, the terpenes. But terpenes can do much more than smell good - they also have a therapeutic...
Terpenes - Scent effect
Cannabis plants emit a very characteristic scent. Responsible for this are scent molecules, the terpenes. But terpenes can do much more than smell good - they also have a therapeutic...
Become a partner of the Medropharm network
Medropharm AG is proud of its select group of partners. They assist us in the selection, procurement and implementation of innovative solutions.Our partners have extensive industry knowledge, simplify process flows,...
Become a partner of the Medropharm network
Medropharm AG is proud of its select group of partners. They assist us in the selection, procurement and implementation of innovative solutions.Our partners have extensive industry knowledge, simplify process flows,...
Medropharm Quality - The Art of Cultivation
Quality management begins with the selection and development of high-quality genetics that carry the potential of a medicinal plant.To ensure that our products meet industry standards as well as the...
Medropharm Quality - The Art of Cultivation
Quality management begins with the selection and development of high-quality genetics that carry the potential of a medicinal plant.To ensure that our products meet industry standards as well as the...
Cannabidiol (CBD) and Dravet syndrome
Only one CBD-based drug is currently approved in Switzerland - Sativex. This THC- and CBD-based oral spray is used for moderate to severe multiple sclerosis. However, for drugs based only...
Cannabidiol (CBD) and Dravet syndrome
Only one CBD-based drug is currently approved in Switzerland - Sativex. This THC- and CBD-based oral spray is used for moderate to severe multiple sclerosis. However, for drugs based only...
Swiss Innovation
Medropharm, based in Switzerland, is a leader in the extraction, manufacturing and development of best and pharmaceutical quality cannabinoid and plant-based products.